1. Headache Classification Committee of the International Headache Society (IHS). 2018; The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38:1–211. DOI:
10.1177/0333102417738202. PMID:
29368949.
4. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. 2000; The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 123(Pt 4):665–76. DOI:
10.1093/brain/123.4.665. PMID:
10733998.
Article
5. Tölle T, Dukes E, Sadosky A. 2006; Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract. 6:153–60. DOI:
10.1111/j.1533-2500.2006.00079.x. PMID:
17147591.
Article
6. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. 2008; Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 71:1183–90. DOI:
10.1212/01.wnl.0000326598.83183.04. PMID:
18716236.
Article
8. Han SH, Lee KH, Kim ME, Kim KS. 2009; Treatment pattern of patients with neuropathic pain in Korea. J Oral Med Pain. 34:197–205.
9. Holland M, Noeller J, Buatti J, He W, Shivapour ET, Hitchon PW. 2015; The cost-effectiveness of surgery for trigeminal neuralgia in surgically naïve patients: a retrospective study. Clin Neurol Neurosurg. 137:34–7. DOI:
10.1016/j.clineuro.2015.06.011. PMID:
26123528.
Article
10. El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Abdel Hakeem M N, Badry R, et al. 2013; Prevalence of trigeminal neuralgia in Al-Quseir city (Red sea Governorate), Egypt. Clin Neurol Neurosurg. 115:1792–4. DOI:
10.1016/j.clineuro.2013.04.014. PMID:
23692870.
Article
11. Mueller D, Obermann M, Yoon MS, Poitz F, Hansen N, Slomke MA, et al. 2011; Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 31:1542–8. DOI:
10.1177/0333102411424619. PMID:
21960648.
Article
12. Lee YS, Kim NH, Sohn HS, Choi KE, Shin HT. 2010; Development of drug utilization review guidelines for therapeutic duplication of antipyretics, analgesics, and anti-inflammatory drugs registered in Korea. Korean J Clin Pharm. 20:213–20. DOI:
10.1111/j.1365-2125.2010.03688.x. PMID:
20653674. PMCID:
PMC2911551.
13. De Toledo IP, Conti Réus J, Fernandes M, Porporatti AL, Peres MA, Takaschima A, et al. 2016; Prevalence of trigeminal neuralgia: a systematic review. J Am Dent Assoc. 147:570–6.e2. DOI:
10.1016/j.adaj.2016.02.014. PMID:
27017183.
14. Katusic S, Beard CM, Bergstralh E, Kurland LT. 1990; Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 27:89–95. DOI:
10.1002/ana.410270114. PMID:
2301931.
Article
15. Hall GC, Carroll D, Parry D, McQuay HJ. 2006; Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 122:156–62. DOI:
10.1016/j.pain.2006.01.030. PMID:
16545908.
Article
16. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC. 2009; Incidence of facial pain in the general population. Pain. 147:122–7. DOI:
10.1016/j.pain.2009.08.023. PMID:
19783099.
Article
19. Girard-Tremblay L, Auclair V, Daigle K, Léonard G, Whittingstall K, Goffaux P. 2014; Sex differences in the neural representation of pain unpleasantness. J Pain. 15:867–77. DOI:
10.1016/j.jpain.2014.05.004. PMID:
24887007.
Article
20. Cui W, Yu X, Zhang H. 2014; The serotonin transporter gene polymorphism is associated with the susceptibility and the pain severity in idiopathic trigeminal neuralgia patients. J Headache Pain. 15:42. DOI:
10.1186/1129-2377-15-42. PMID:
24950698. PMCID:
PMC4080683.
Article
21. Bang S, Kim YS, Lee S, Park U, Kim TK, Choi Y. 2020; Prevalence of common causes of neuropathic pain in Korea: population-based observational study. J Int Med Res. 48:300060519888102. DOI:
10.1177/0300060519888102. PMID:
31775560. PMCID:
PMC7516997.
Article
24. Di Stefano G, La Cesa S, Truini A, Cruccu G. 2014; Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 15:34. DOI:
10.1186/1129-2377-15-34. PMID:
24912658. PMCID:
PMC4067104.
Article
27. Galluzzi KE. 2005; Management of neuropathic pain. J Am Osteopath Assoc. 105(9 Suppl 4):S12–9. PMID:
16273720.